Vir Biotechnology, Inc.
VIR
$9.40
$0.111.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.91% | 58.96% | 23.66% | 19.82% | -85.31% |
| Total Depreciation and Amortization | -1.95% | 0.42% | 3.52% | -31.53% | -36.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.33% | -45.31% | -39.70% | -77.76% | -58.46% |
| Change in Net Operating Assets | -187.04% | 83.27% | -217.77% | -1,403.36% | 131.72% |
| Cash from Operations | -69.47% | 70.47% | 2.28% | -54.43% | 28.59% |
| Capital Expenditure | 76.06% | 82.56% | 88.55% | -281.08% | 12.98% |
| Sale of Property, Plant, and Equipment | -- | -104.48% | 640.00% | -88.13% | -47.28% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -90.46% | -37.90% | -66.44% | -72.18% | 330.68% |
| Cash from Investing | -90.67% | -38.43% | -65.90% | -73.32% | 346.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27,077.76% | -16.72% | 42.25% | -20.09% | 170.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -115.38% | 102.50% | -160.87% | -- |
| Cash from Financing | 27,077.76% | -17.74% | 229.03% | -30.46% | 293.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.86% | 13.70% | -140.36% | -145.15% | 161.00% |